GGrantIndex
Sort

34,240 grants matching atherosclerosis

Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosis

$538,073
Edward A Fisher · New York University School Of Medicine · R01 · FY2014 · HL

The role of TFEB in aortic aneurysms

$538,002
Yanbo Fan · University Of Cincinnati · R01 · FY2021 · HL

Coronary Artery Dynamic Geometry and Atherosclerosis

$537,980
Morton H Friedman · Duke University · R01 · FY2007 · HL

Lipoprotein Interactions in the Vessel Wall

$537,945
Amy Sanghavi Shah · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

Impact of dyslipidemia on endothelial biomechanics

$537,881
Irena Levitan · University Of Illinois At Chicago · R01 · FY2014 · HL

Role of IL1b in Regulating SMC and Macrophage Differentiation in Atherosclerosis

$537,862
Gary K Owens · University Of Virginia · R01 · FY2015 · HL

ACHIEVE P1 - HTN

$537,803
Robert D Brook · Wayne State University · P50 · FY2021 · MD

Systems biology of macrophage activation and plasticity

$537,787
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Role of Notch Signaling in atherosclerosis and Stem Cell Mediated Arterial Repair

$537,609
Omaida C Velazquez · University Of Miami School Of Medicine · R01 · FY2017 · HL

Micro-Mechanical Role of Hypertension in Intimal Hyperplasia

$537,566
Ghassan S Kassab · Indiana University Indianapolis · R01 · FY2013 · HL

MRI Assessment of Vascular Reactivity

$537,540
Felix W Wehrli · University Of Pennsylvania · R01 · FY2012 · HL

Small molecule allosteric inhibitors of PCSK9 processing to phenocopy cardioprotective genetic variants.

$537,538
John S Chorba · University Of California, San Francisco · R61 · FY2023 · HL

Identifying Atherosclerosis Modifier Genes in the Mouse

$537,526
Jan L Breslow · Columbia University Health Sciences · P01 · FY2008 · HL

Core K--Structural Lipidomics/Other Lipids

$537,299
Christian R Raetz · University Of California, San Diego · U54 · FY2007 · GM

Development of hMaxiK bladder wall injection for overactive bladder treatment

$537,254
Sharon Gail Jacobs · Ion Channel Innovations, Llc · R44 · FY2013 · AG

Role of the Follicle-Depleted Ovary in the Pathogenesis of Chronic Diseases

$537,252
Jay R Kaplan · Wake Forest University Health Sciences · R01 · FY2007 · AG

Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease

$537,250
Omaida C Velazquez · University Of Miami School Of Medicine · R33 · FY2023 · HL

Combining Targeted Demethylation with Noncoding RNA-mediated mRNA Stabilization as a Strategy for Therapeutic Arteriogenesis in the Aged

$537,039
Alan Ross Morrison · Ocean State Research Institute, Inc. · R01 · FY2022 · HL

Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization

$537,006
Mary G Sorci-Thomas · Medical College Of Wisconsin · R01 · FY2017 · HL

Biogenesis of HDL Through Cholesterol Efflux and ApoA-I Structural Reorganization

$537,006
Mary G Sorci-Thomas · Medical College Of Wisconsin · R01 · FY2018 · HL

Chlamydia pneumoniae vaccine candidates

$536,939
Auburn University At Auburn · R01 · FY2001 · AI

Apolipoprotein-C Proteoforms in Dyslipidemia and Cardiovascular Disease

$536,771
Peter D Reaven · Arizona State University-Tempe Campus · R01 · FY2018 · HL

Post-DPP Follow-up Study

$536,768
Karol E Watson · University Of California Los Angeles · U01 · FY2006 · DK

Lipoprotein Interactions in the Vessel Wall

$536,748
Amy Sanghavi Shah · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL

Determinants of Accelerated CVD in Type 1 Diabetes

$536,735
Marian J. Rewers · University Of Colorado Denver · R01 · FY2007 · HL